Remove .Net Remove Competition Remove Report Remove Workshop
article thumbnail

Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More

Xconomy

Critics say Mylan has been emboldened by the recall of EpiPen’s only competition last fall. —A five-day workshop in Washington, D.C., Frank Vinluan has more on Novan, which relied on a variety of high net worth individuals, rather than venture firms, to get to this point. Alex Lash contributed to this report.

Pricing 40
article thumbnail

Why You Should Start a Company in. Los Angeles

SoCal Delicious

Because its just not that hyper-competitive, Im-hiring-all-your-staff, because-Im-Google environment. Report Content February 27, 2010 at 11:05am by Antone Johnson Great interview. Dropped Calls, Students Protest AT&T Network Coverage Facebook Patents News Feed, Social Net Confusion Ensues Trying to Work from Home More Efficiently?